A nurse holds a bag of plasma from a recovered coronavirus disease (COVID-19) donor next to an apheresis machine at the Belgian Red Cross blood collection center in Brussels, Belgium October 27, 2020. Picture taken October 27, 2020. REUTERS/Francois Lenoir
BRUSSELS (Reuters) - Belgian clinical studies to study the effectiveness of blood plasma for people recovering from COVID-19 are at risk of being suspended because of low plasma stocks, doctors said, prompting a call for more blood donors to come forward.
The Belgian Red Cross is supplying plasma to two hospitals, University Hospital Leuven and CHU of Liege, which are leading two clinical studies in the country to see how plasma containing antibodies from COVID-19 survivors can help infected people.
Limited time offer:
Just RM5 per month.
